(Total Views: 774)
Posted On: 07/20/2022 1:06:54 PM
Post# of 154128
Quote:
GSK’s attention on two therapeutic areas in which it already has a sizable presence—respiratory and HIV/infectious diseases—and two in which it aspires to grow—oncology and immuno-inflammation.
We have indications in all four areas.
(12)
(0)
